{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:54:49Z","timestamp":1746712489885,"version":"3.40.5"},"reference-count":48,"publisher":"American Academy of Pediatrics (AAP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:p>Sexually transmitted infections (STIs) affect young people in a disproportionate way, with more than half of the infections occurring in 15- to 25-year-olds, although as an age group they constitute only 25% of the sexually active population. Pediatricians should be familiar with the social, behavioral, and biological factors that predispose adolescents to STIs. Preventive visits for teens and pre-teens should incorporate education and counseling about sexuality, safe sexual behavior, and STIs. Pediatricians should be able to identify, diagnose, and manage STIs presenting as genital \u201cbumps\u201d and genital \u201culcers.\u201d Pediatricians should also offer human immunodeficiency virus testing and expedited partner treatment to all adolescents who are diagnosed as having an STI.<\/jats:p>","DOI":"10.1542\/pir.2018-0261","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T13:20:17Z","timestamp":1598966417000},"page":"455-468","source":"Crossref","is-referenced-by-count":3,"title":["Sexually Transmitted Infections: Part I: Genital Bumps and Genital Ulcers"],"prefix":"10.1542","volume":"41","author":[{"given":"Nupur","family":"Gupta","sequence":"first","affiliation":[{"name":"Division of Adolescent and Young Adult Medicine and Division of Global Health, MassGeneral Hospital for Children, Boston, MA"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"issue":"3","key":"2022041520361771100_B1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008","volume":"40","author":"Satterwhite","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"6","key":"2022041520361771100_B2","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1542\/peds.2009-0674","article-title":"Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States","volume":"124","author":"Forhan","year":"2009","journal-title":"Pediatrics"},{"volume-title":"Sexually Transmitted Disease Surveillance 2018","year":"2019","author":"Centers for Disease Control and Prevention","key":"2022041520361771100_B3"},{"issue":"32","key":"2022041520361771100_B4","doi-asserted-by":"crossref","first-page":"11308","DOI":"10.1523\/JNEUROSCI.1553-15.2015","article-title":"Longitudinal changes in prefrontal cortex activation underlie declines in adolescent risk taking","volume":"35","author":"Qu","year":"2015","journal-title":"J Neurosci"},{"issue":"8","key":"2022041520361771100_B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6708a1","article-title":"Youth Risk Behavior Surveillance - United States, 2017","volume":"67","author":"Kann","year":"2018","journal-title":"MMWR Surveill Summ"},{"issue":"1","key":"2022041520361771100_B6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jadohealth.2016.03.014","article-title":"Sexually transmitted infection services for adolescents and youth in low- and middle-income countries: perceived and experienced barriers to accessing care","volume":"59","author":"Newton-Levinson","year":"2016","journal-title":"J Adolesc Health"},{"issue":"2","key":"2022041520361771100_B7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jadohealth.2005.11.022","article-title":"Predictors of timely initiation of gynecologic care among urban adolescent girls","volume":"39","author":"McKee","year":"2006","journal-title":"J Adolesc Health"},{"issue":"12","key":"2022041520361771100_B8","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/archpediatrics.2009.203","article-title":"Time from first intercourse to first sexually transmitted infection diagnosis among adolescent women","volume":"163","author":"Tu","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"2022041520361771100_B9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2458-4-21","article-title":"Barriers to asymptomatic screening and other STD services for adolescents and young adults: focus group discussions","volume":"4","author":"Tilson","year":"2004","journal-title":"BMC Public Health"},{"issue":"2","key":"2022041520361771100_B10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/sextrans-2014-051674","article-title":"Cervical ectopy: associations with sexually transmitted infections and HIV: a cross-sectional study of high school students in rural South Africa","volume":"91","author":"Kleppa","year":"2015","journal-title":"Sex Transm Infect"},{"issue":"5","key":"2022041520361771100_B11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/1054-139X(94)90268-2","article-title":"Secretory IgA in cervical mucus","volume":"15","author":"McGrath","year":"1994","journal-title":"J Adolesc Health"},{"key":"2022041520361771100_B12","unstructured":"National STD Curriculum. Self-study modules: HPV. Available at: https:\/\/www.std.uw.edu\/custom\/self-study\/hpv\/3 Accessed August 17, 2018"},{"issue":"8","key":"2022041520361771100_B13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"issue":"8","key":"2022041520361771100_B14","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2105\/AJPH.2012.301182","article-title":"Prevalence of anogenital warts among participants in private health plans in the United States, 2003\u20132010: potential impact of human papillomavirus vaccination","volume":"103","author":"Flagg","year":"2013","journal-title":"Am J Public Health"},{"issue":"1","key":"2022041520361771100_B15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2105\/AJPH.2017.304119","article-title":"Declines in anogenital warts among age groups most likely to be impacted by human papillomavirus vaccination, United States, 2006-2014","volume":"108","author":"Flagg","year":"2018","journal-title":"Am J Public Health"},{"issue":"5","key":"2022041520361771100_B16","first-page":"316","article-title":"Topical anaesthesia with local anaesthetic (lidocaine and prilocaine, EMLA) cream for cautery of genital warts","volume":"63","author":"Hall\u00e9n","year":"1987","journal-title":"Genitourin Med"},{"issue":"RR-03","key":"2022041520361771100_B17","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep"},{"issue":"11","key":"2022041520361771100_B18","first-page":"300","article-title":"Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"19","key":"2022041520361771100_B19","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"issue":"11","key":"2022041520361771100_B20","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/OLQ.0000000000000043","article-title":"Trends in seroprevalence of herpes simplex virus type 2 among non-Hispanic blacks and non-Hispanic whites aged 14 to 49 years\u2014United States, 1988 to 2010","volume":"40","author":"Fanfair","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"3","key":"2022041520361771100_B21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/infdis\/jit458","article-title":"Seroprevalence of herpes simplex virus types 1 and 2\u2014United States, 1999\u20132010","volume":"209","author":"Bradley","year":"2014","journal-title":"J Infect Dis"},{"issue":"8","key":"2022041520361771100_B22","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jama.296.8.964","article-title":"Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States","volume":"296","author":"Xu","year":"2006","journal-title":"JAMA"},{"issue":"10","key":"2022041520361771100_B23","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1177\/0956462414552814","article-title":"Disparities in herpes simplex virus type 2 infection between black and white men who have sex with men in Atlanta, GA","volume":"26","author":"Okafor","year":"2015","journal-title":"Int J STD AIDS"},{"issue":"6","key":"2022041520361771100_B24","doi-asserted-by":"crossref","first-page":"958","DOI":"10.7326\/0003-4819-98-6-958","article-title":"Genital herpes simplex virus infections: clinical manifestations, course, and complications","volume":"98","author":"Corey","year":"1983","journal-title":"Ann Intern Med"},{"issue":"4","key":"2022041520361771100_B25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00007435-200304000-00007","article-title":"Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2","volume":"30","author":"Ashley-Morrow","year":"2003","journal-title":"Sex Transm Dis"},{"issue":"19","key":"2022041520361771100_B26","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1056\/NEJMcp023065","article-title":"Clinical practice: genital herpes","volume":"350","author":"Kimberlin","year":"2004","journal-title":"N Engl J Med"},{"issue":"6","key":"2022041520361771100_B27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11908-009-0066-7","article-title":"New concepts in understanding genital herpes","volume":"11","author":"Schiffer","year":"2009","journal-title":"Curr Infect Dis Rep"},{"issue":"1","key":"2022041520361771100_B28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/588676","article-title":"Herpes simplex virus viremia during primary genital infection","volume":"198","author":"Johnston","year":"2008","journal-title":"J Infect Dis"},{"issue":"4","key":"2022041520361771100_B29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/QAD.0b013e32835049be","article-title":"Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment","volume":"26","author":"Di Lucca-Christment","year":"2012","journal-title":"AIDS"},{"issue":"19","key":"2022041520361771100_B30","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM199911043411904","article-title":"A prospective study of new infections with herpes simplex virus type 1 and type 2","volume":"341","author":"Langenberg","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"2022041520361771100_B31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7326\/0003-4819-131-1-199907060-00004","article-title":"Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time","volume":"131","author":"Benedetti","year":"1999","journal-title":"Ann Intern Med"},{"issue":"12","key":"2022041520361771100_B32","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1056\/NEJM200003233421203","article-title":"Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons","volume":"342","author":"Wald","year":"2000","journal-title":"N Engl J Med"},{"issue":"3","key":"2022041520361771100_B33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/505496","article-title":"Management of herpes simplex virus type 2 infection in HIV type 1-infected persons","volume":"43","author":"Strick","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2022041520361771100_B34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/422755","article-title":"Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy","volume":"190","author":"Posavad","year":"2004","journal-title":"J Infect Dis"},{"issue":"5","key":"2022041520361771100_B35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/infdis\/jit252","article-title":"Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy","volume":"208","author":"Tobian","year":"2013","journal-title":"J Infect Dis"},{"issue":"9","key":"2022041520361771100_B36","doi-asserted-by":"crossref","first-page":"e0163541","DOI":"10.1371\/journal.pone.0163541","article-title":"Genital HSV shedding among Kenyan women initiating antiretroviral therapy","volume":"11","author":"Manguro","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"2022041520361771100_B37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1128\/CMR.00043-15","article-title":"Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract shedding","volume":"29","author":"Johnston","year":"2016","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"2022041520361771100_B38","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1128\/JVI.03285-13","article-title":"Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection","volume":"88","author":"Johnston","year":"2014","journal-title":"J Virol"},{"issue":"2","key":"2022041520361771100_B39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12160-014-9640-9","article-title":"Psychological distress, emotional stability, and emotion regulation moderate dynamics of herpes simplex virus type 2 recurrence","volume":"49","author":"Horn","year":"2015","journal-title":"Ann Behav Med"},{"issue":"9","key":"2022041520361771100_B40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.olq.0000204723.15765.91","article-title":"Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding","volume":"33","author":"Wald","year":"2006","journal-title":"Sex Transm Dis"},{"key":"2022041520361771100_B41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1743-422X-11-83","article-title":"Diagnosis of genital herpes simplex virus infection in the clinical laboratory","volume":"11","author":"LeGoff","year":"2014","journal-title":"Virol J"},{"issue":"11","key":"2022041520361771100_B42","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1128\/JCM.01685-12","article-title":"Type-specific identification of anogenital herpes simplex virus infections by use of a commercially available nucleic acid amplification test","volume":"50","author":"Van Der Pol","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"9","key":"2022041520361771100_B43","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1086\/379043","article-title":"Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture","volume":"188","author":"Wald","year":"2003","journal-title":"J Infect Dis"},{"issue":"23","key":"2022041520361771100_B44","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/jama.2016.16776","article-title":"Serologic screening for genital herpes infection: US Preventive Services Task Force recommendation statement","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"2022041520361771100_B45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clp.2014.10.005","article-title":"Neonatal herpes simplex virus infection: epidemiology and treatment","volume":"42","author":"James","year":"2015","journal-title":"Clin Perinatol"},{"issue":"16","key":"2022041520361771100_B46","doi-asserted-by":"crossref","first-page":"8497","DOI":"10.1128\/JVI.01089-15","article-title":"A dual-modality herpes simplex virus 2 vaccine for preventing genital herpes by using glycoprotein C and D subunit antigens to Induce potent antibody responses and adenovirus vectors containing capsid and tegument proteins as T cell immunogens","volume":"89","author":"Awasthi","year":"2015","journal-title":"J Virol"},{"issue":"12","key":"2022041520361771100_B47","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1586\/erv.12.129","article-title":"The challenge of developing a herpes simplex virus 2 vaccine","volume":"11","author":"Dropulic","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"23","key":"2022041520361771100_B48","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/jama.2019.2592","article-title":"Screening for HIV infection in asymptomatic, nonpregnant adolescents and adults: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"321","author":"Chou","year":"2019","journal-title":"JAMA"}],"container-title":["Pediatrics In Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/41\/9\/455\/1279205\/pedsinreview_20180261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/41\/9\/455\/1279205\/pedsinreview_20180261.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T20:38:52Z","timestamp":1650055132000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article\/41\/9\/455\/963\/Sexually-Transmitted-Infections-Part-I-Genital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,1]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/pir.2018-0261","relation":{},"ISSN":["0191-9601","1526-3347"],"issn-type":[{"type":"print","value":"0191-9601"},{"type":"electronic","value":"1526-3347"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}